Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00389779
Status:
COMPLETED
Last Update Posted:
2014-03-18
First Post:
2006-10-17
Brief Title:
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
Sponsor:
Organization:
Gilead Sciences